Stockscreener 앱 받기
43.89
0.09%
0.04
시간 외 거래:
43.89
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million -- WSJ - Moomoo
XOMAO Stock Price, Quote & Chart - ChartMill
XOMA Royalty (XOMA) Stock Fair Value Falls After Ligand Agrees Cash Acquisition - Yahoo Finance
XOMA Royalty Sets July Vote on $39-per-Share Ligand Takeover and Reorganization - TipRanks
XOMA Royalty Corp (XOMA) Institutional Confidence - TradingKey
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
XOMA Royalty Corp (XOMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XOMA Royalty Corp (XOMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XOMA Royalty Corp (XOMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
XOMA Royalty Corp (XOMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XOMA Royalty Corp (XOMA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XOMAP | XOMA Royalty Corporation 8.625% Insider Trading - Quiver Quantitative
XOMA Royalty Corp (XOMA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
XOMA Royalty Corp (XOMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XOMA Royalty Corp (XOMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XOMA Q1 2026 Earnings: EPS Misses Expectations, No Revenue ReportedQuarterly Financial Update - newsline.com
XOMA Royalty Corp Declares Preferred Stock Dividend, Announces Redemption and CVR Record Date Ahead of Ligand Merger – Minichart - Minichart
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date - The Manila Times
XOMA Details Merger Timeline and Preferred Share Redemption - TipRanks
XOMA Royalty (XOMA) Holds Steady Near $42 as Trading Range Remains IntactPCR Extreme - newsline.com
XOMA Royalty expects HoldCo acquisition to close ~July 14; redeems preferred stock - TradingView
XOMA (XOMA) to redeem all preferred shares and issue CVRs ahead of Ligand deal - Stock Titan
Investors in XOMA face preferred stock redemption, new CVR rights - Stock Titan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-TMHC, CZR, XOMA, and RAMP - The Malaysian Reserve
XOMAO Q1 2026 Earnings: Preferred Stock EPS Misses Consensus as Revenue AbsentEPS Growth Report - dars.gov.et
Ligand to Buy XOMA Royalty (NASDAQ: XOMA) for $39.00 Cash Plus CVR - Stock Titan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger–TMHC, CZR, XOMA, and RAMP - Weekly Voice
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, CZR, XOMA, and RAMP - Sahm
XOMA Royalty Holds Steady Near Support Levels After Modest GainDividend Stock Picks - newsline.com
XOMA Royalty Holds Steady Near $42 as Resistance at $44.28 LoomsMFI Oversold - newsline.com
XOMAO Q1 2026 Earnings: EPS Misses Estimates Amidst Royalty Revenue ChallengesEarnings Sentiment Score - dars.gov.et
Ligand set to report earnings as XOMA deal reshapes growth outlook - Investing.com
XOMA (XOMA) Q4 2025 Earnings Call Transcript - AOL.com
Ligand Shares Hold Up in Biotech Rout While XOMA Deal Heads for Investor Vote - Bez Kabli
XOMA ROYALTY CORPXOMA 8 5/8 PERP (XOMAP) Stock Price & Overview - ChartMill
[Form 4] XOMA Royalty Corp Insider Trading Activity - Stock Titan
Director at XOMA (XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
Director at XOMA (NASDAQ: XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
XOMA Royalty Corp (XOMA) director receives 3,586 RSU equity grant - Stock Titan
Equity grant: XOMA (XOMA) director awarded 3,586 RSUs of common stock - Stock Titan
XOMAXOMA Royalty Corp Stock Price and Quote - Finviz
XOMA Royalty (XOMA) merger: $39.00 cash + one CVR tied to Janssen litigation - Stock Titan
XOMAP Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Royalty FluctuationsBasic EPS Analysis - thelegaladvocate.com
Saying Goodbye To The XOMA Royalty PFDs (NASDAQ:XOMAO) - Seeking Alpha
XOMA Royalty Corporation (Formerly XOMA Corp) Files Form 8-K Detailing Bylaws Amendments and Stock Awards – May 2026 - Minichart
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes By Investing.com - Investing.com South Africa
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes - Investing.com UK
XOMA (NASDAQ: XOMA) shareholders approve equity plans and new bylaw provisions - Stock Titan
XOMAO Stock Price and Chart — NASDAQ:XOMAO - TradingView
BVF group (NASDAQ: XOMA) converts 5,003 Series X preferred into common - Stock Titan
BVF group boosts XOMA (XOMA) ownership to 43.3% after Series X share conversion - Stock Titan
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals By Investing.com - Investing.com Canada
Ligand Pharmaceuticals Files 8-K Announcing Amendment No. 1 to Agreement and Plan of Merger with XOMA Royalty Corporation 10 - Minichart
XOMA Royalty Corp Announces SEC Filing for Merger Agreement with Ligand Pharmaceuticals - Minichart
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals - Investing.com
1.17%
2.48%
자본화:
|
볼륨(24시간):